Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | JNJ | LLY | NVO | MRK | ABBV |
| Company | Johnson & Johnson | Eli Lilly and Company | Novo Nordisk A/S ADR | Merck & Company | Abbvie Inc |
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | NYSE | NYSE |
| Open | 149.89 | 743.00 | 122.92 | 128.01 | 161.16 |
| High | 149.89 | 745.00 | 123.77 | 128.48 | 163.23 |
| Low | 147.82 | 730.34 | 121.29 | 127.18 | 160.74 |
| Last | 148.67 | 737.50 | 122.90 | 127.63 | 162.94 |
| Change | -1.25 | -18.41 | -1.12 | -0.63 | +2.13 |
| % Change | -0.83% | -2.44% | -0.90% | -0.49% | +1.32% |
| Volume | 2,563,962 | 2,290,335 | 3,648,160 | 1,739,689 | 1,776,617 |
| 20-Day Average Volume | 8,451,294 | 2,631,132 | 3,829,884 | 6,725,411 | 5,185,410 |
| Previous Close | 149.92 | 755.91 | 124.02 | 128.26 | 160.81 |
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 148.11 | 749.03 | 125.42 | 127.33 | 164.99 |
| 20-Day Raw Stochastic | 55.17% | 20.15% | 15.60% | 41.20% | 34.57% |
| 20-Day Relative Strength | 44.68% | 46.30% | 45.54% | 53.66% | 41.25% |
| Weighted Alpha | -9.91 | +66.58 | +50.33 | +14.49 | +10.06 |
| Today's Opinion | 88% Sell | 48% Buy | 40% Buy | 100% Buy | 8% Buy |
| Previous Opinion | 88% Sell | 64% Buy | 40% Buy | 100% Buy | 8% Buy |
| Last Month's Opinion | 56% Sell | 100% Buy | 80% Buy | 88% Buy | 64% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.68% since 04/26/24 | +0.05% since 04/26/24 | -3.21% since 04/26/24 | -2.50% since 04/26/24 | +1.87% since 04/26/24 |
| Low | 144.53 on 04/30/24 | 729.61 on 04/29/24 | 121.36 on 05/03/24 | 127.18 on 05/03/24 | 158.12 on 05/02/24 |
| High | 152.33 on 05/02/24 | 795.50 on 04/30/24 | 130.46 on 04/30/24 | 132.20 on 04/29/24 | 163.69 on 05/01/24 |
| 1-Month | |||||
| %Chg | -3.67% since 04/03/24 | -5.43% since 04/03/24 | -3.32% since 04/03/24 | -1.52% since 04/03/24 | -8.31% since 04/03/24 |
| Low | 143.13 on 04/18/24 | 718.30 on 04/25/24 | 121.36 on 05/03/24 | 124.50 on 04/18/24 | 157.65 on 04/26/24 |
| High | 155.50 on 04/04/24 | 795.50 on 04/30/24 | 130.46 on 04/30/24 | 132.80 on 04/25/24 | 177.70 on 04/04/24 |
| 3-Month | |||||
| %Chg | -5.12% since 02/02/24 | +9.92% since 02/02/24 | +7.99% since 02/02/24 | +1.19% since 02/02/24 | -3.60% since 02/02/24 |
| Low | 143.13 on 04/18/24 | 682.53 on 02/05/24 | 116.27 on 02/05/24 | 119.23 on 03/15/24 | 157.65 on 04/26/24 |
| High | 163.11 on 03/12/24 | 800.78 on 03/04/24 | 138.28 on 03/07/24 | 133.10 on 03/27/24 | 182.89 on 03/12/24 |
| 6-Month | |||||
| %Chg | -1.81% since 11/03/23 | +29.24% since 11/03/23 | +25.07% since 11/03/23 | +23.74% since 11/03/23 | +14.98% since 11/03/23 |
| Low | 143.13 on 04/18/24 | 561.65 on 12/15/23 | 94.73 on 12/11/23 | 99.80 on 11/29/23 | 135.85 on 11/09/23 |
| High | 163.58 on 01/22/24 | 800.78 on 03/04/24 | 138.28 on 03/07/24 | 133.10 on 03/27/24 | 182.89 on 03/12/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 361,274,624 | 718,420,608 | 556,543,744 | 324,886,144 | 284,737,728 |
| Shares Outstanding, K | 2,409,783 | 950,405 | 4,487,532 | 2,533,028 | 1,770,647 |
| Annual Sales | 85,159,000,000 | 34,124,100,000 | 33,724,300,000 | 60,115,000,000 | 54,318,000,000 |
| Annual Net Income | 35,153,000,000 | 5,240,400,000 | 12,150,770,000 | 365,000,000 | 4,863,000,000 |
| Last Quarter Sales | 21,383,000,000 | 9,353,400,000 | 9,526,160,000 | 15,775,000,000 | 12,310,000,000 |
| Last Quarter Net Income | 5,354,000,000 | 2,189,700,000 | 3,175,360,000 | 4,762,000,000 | 1,369,000,000 |
| 60-Month Beta | 0.55 | 0.37 | 0.43 | 0.39 | 0.61 |
| Per-Share Information | |||||
| Most Recent Earnings | 2.71 on 04/16/24 | 2.58 on 04/30/24 | 0.71 on 01/31/24 | 2.07 on 04/25/24 | 2.31 on 04/26/24 |
| Latest Earnings Date | 04/16/24 | 04/30/24 | 05/02/24 | 04/25/24 | 04/26/24 |
| Most Recent Dividend | 1.190 on 02/16/24 | 1.300 on 02/14/24 | 0.663 on 03/22/24 | 0.770 on 03/14/24 | 1.550 on 04/12/24 |
| Next Ex-Dividends Date | 05/20/24 | 02/14/24 | 03/22/24 | 03/14/24 | 04/12/24 |
| Ratios | |||||
| Price/Earnings ttm | 14.45 | 106.70 | 47.77 | 59.35 | 14.76 |